News
Latest News, Announcements, and Press Releases
01Mar 18
Codexis to Hold 2017 Fourth Quarter and Full Year Conference Call on March 8
REDWOOD CITY, Calif. , March 01, 2018 (GLOBE NEWSWIRE) — Codexis, Inc. (NASDAQ:CDXS), a leading protein engineering company, announces that it will report fourth quarter and full year 2017 financial results after market close on Thursday, March 8, 2018 .
read more15Feb 18
Codexis Appoints Molecular Diagnostics Industry Veteran Shawn Clairmont to Lead High-Performance Enzymes Commercialization
REDWOOD CITY, Calif. , Feb. 15, 2018 (GLOBE NEWSWIRE) — Codexis, Inc. (NASDAQ:CDXS), a leading protein engineering company, announces the appointment of Shawn Clairmont to the newly created position of Senior Director, Molecular Diagnostics. Codexis is expanding into the molecular…
read more12Feb 18
Codexis to Present at the 25th International Molecular Medicine Tri-Conference
REDWOOD CITY, Calif., Feb. 12, 2018 (GLOBE NEWSWIRE) — Codexis, Inc. (NASDAQ:CDXS), a leading protein engineering company, announces that John Nicols, President & CEO, will discuss the development of an improved DNA ligase for the molecular diagnostics industry…
read more18Dec 17
Codexis named as one of the nation’s Best & Brightest Companies to Work For®
Codexis is pleased to announce we’ve been selected as one of the nation’s Best and Brightest Companies to Work For®. December 18, 2017– Warren, MI — The National Association for Business Resources has named the Best and Brightest Companies To…
read more09Nov 17
Codexis Reports Financial Results for the Third Quarter of 2017
Product sales increase 71% over the prior year Affirms 2017 revenue guidance Conference call begins at 4:30 pm Eastern time today REDWOOD CITY, Calif., Nov. 09, 2017 (GLOBE NEWSWIRE) — Codexis, Inc. (NASDAQ:CDXS), a leading protein engineering company,…
read more09Nov 17
Codexis to Present at Two Investment Conferences in November
REDWOOD CITY, Calif., Nov. 09, 2017 (GLOBE NEWSWIRE) — Codexis, Inc. (NASDAQ:CDXS), a leading protein engineering company, announces that management will present at two investment conferences in November: 8th Annual Craig-Hallum Alpha Select Conference on Thursday, November 16,…
read more02Nov 17
Codexis to Hold 2017 Third Quarter Conference Call on November 9
REDWOOD CITY, Calif, Nov. 02, 2017 (GLOBE NEWSWIRE) — Codexis, Inc. (NASDAQ:CDXS), a leading protein engineering company, announces that it will report third quarter 2017 financial results after market close on Thursday, November 9, 2017. Codexis management will…
read more12Oct 17
Codexis and Nestlé Health Science Enter Into Healthcare-Focused Protein Engineering Platform Partnership
Includes an option for the global development of CDX-6114 for PKU, marking Codexis’ first partnership for an internally developed biotherapeutic product. Codexis receives an upfront payment of $14 million and potential milestones and royalties depending on product success…
read more31Aug 17
Codexis to Present at Four Investment Conferences in September
REDWOOD CITY, Calif., Aug. 31, 2017 (GLOBE NEWSWIRE) — Codexis, Inc. (NASDAQ:CDXS), a leading protein engineering company, announces that management will present at four investment conferences in September: BioCentury 24th Annual NewsMakers in the Biotech Industry Conference on…
read more09Aug 17
Codexis Reports Financial Results for the Second Quarter of 2017
Product sales more than doubled versus prior-year second quarter Affirms 2017 total revenue guidance; increases full year product sales and gross margin guidance Conference call begins at 4:30 pm Eastern time today REDWOOD CITY, Calif., Aug. 09, 2017…
read moreSince 2002, Codexis has created new technologies to unlock the power of proteins™. Put our unmatched protein engineering expertise to work for you.
Unlock the power of proteins™ with Codexis
Learn More
Company
Industries